come back to us when they miss an end point in Phase 2... very easy to do.. statistically a miracle to make it through 3 phases, without having to go back and repeat something, or revise an endpoint, or select the wrong patients, or safety or efficacy issues. 17 patients ahahah you have NOTHING YET.
Stem cells ramping up.., page-57
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 72431 | 94.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 20225 | 5 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |